Filter By Unselect All
Sub Category Unselect
Companies Unselect See All
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
PPD’s Phase I clinic conducts approximately 100 studies per year and has sufficient capacity to carry out multiple studies of varying design simultaneously. Research-experienced, board-certified physicians serve as principal investigators for Phase I studies. Secure and confidential drug
With more than 40 years of experience in performing bioequivalence studies, our clinical unit in Bloemfontein, South Africa, is a center of excellence. It is strategically placed in the perfect location for these trials a lower cost and fast start-up environment.
MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification
PAREXEL’s global team of experienced clinical pharmacokineticists and pharmacometricians offer unsurpassed expertise in Clinical PK/PD and Pharmacometrics, from pre-clinical to Phase III studies.
Quotient has the experience and expertise to seamlessly deliver your studies with the highest quality service and speed to clinical data. If you need a complete service including data management, data analysis, statistics and medical writing, Quotient is your answer.
The ADME (Absorption, Distribution, Metabolism and Excretion) Suite includes new state-of-the-art equipment and laboratory space to perform on-site scintillation counting allowing for radioactivity recovery results to be delivered in real-time.